FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first medication for certain patients with the condition.
Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
Her doctor was on board, so long as Hasan also agreed to start resistance training—something she had only done briefly in the ...
People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...
"The main finding is that approximately 50% of patients who consumed alcohol at baseline reported decreased alcohol use after ...
Anti-obesity medications linked to reduced alcohol ... Study: Alcohol Use and Antiobesity Medication Treatment. Image Credit: PeopleImages.com - Yuri A / Shutterstock.com In a recent study ...
This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback